BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7866743)

  • 1. The structure of Pneumocystis carinii dihydrofolate reductase to 1.9 A resolution.
    Champness JN; Achari A; Ballantine SP; Bryant PK; Delves CJ; Stammers DK
    Structure; 1994 Oct; 2(10):915-24. PubMed ID: 7866743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into DHFR interactions: analysis of Pneumocystis carinii and mouse DHFR complexes with NADPH and two highly potent 5-(omega-carboxy(alkyloxy) trimethoprim derivatives reveals conformational correlations with activity and novel parallel ring stacking interactions.
    Cody V; Pace J; Chisum K; Rosowsky A
    Proteins; 2006 Dec; 65(4):959-69. PubMed ID: 17019704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural studies on bioactive compounds. 30. Crystal structure and molecular modeling studies on the Pneumocystis carinii dihydrofolate reductase cofactor complex with TAB, a highly selective antifolate.
    Cody V; Chan D; Galitsky N; Rak D; Luft JR; Pangborn W; Queener SF; Laughton CA; Stevens MF
    Biochemistry; 2000 Apr; 39(13):3556-64. PubMed ID: 10736154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductases by 2,4-diamino-5-[2-methoxy-5-(omega-carboxyalkyloxy)benzyl]pyrimidines: marked improvement in potency relative to trimethoprim and species selectivity relative to piritrexim.
    Rosowsky A; Forsch RA; Queener SF
    J Med Chem; 2002 Jan; 45(1):233-41. PubMed ID: 11754594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and expression of the Pneumocystis carinii dihydrofolate reductase gene.
    Edman JC; Edman U; Cao M; Lundgren B; Kovacs JA; Santi DV
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8625-9. PubMed ID: 2682653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-induced conformational changes in the crystal structures of Pneumocystis carinii dihydrofolate reductase complexes with folate and NADP+.
    Cody V; Galitsky N; Rak D; Luft JR; Pangborn W; Queener SF
    Biochemistry; 1999 Apr; 38(14):4303-12. PubMed ID: 10194348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular model of the folate binding site of Pneumocystis carinii dihydrofolate reductase.
    Southerland WM
    J Comput Aided Mol Des; 1994 Apr; 8(2):113-22. PubMed ID: 8064329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based enzyme inhibitor design: modeling studies and crystal structure analysis of Pneumocystis carinii dihydrofolate reductase ternary complex with PT653 and NADPH.
    Cody V; Galitsky N; Luft JR; Pangborn W; Rosowsky A; Queener SF
    Acta Crystallogr D Biol Crystallogr; 2002 Jun; 58(Pt 6 Pt 2):946-54. PubMed ID: 12037296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of quinazoline and pyrido[2,3-d]pyrimidine N9-C10 reversed-bridge antifolates in complex with NADP+ and Pneumocystis carinii dihydrofolate reductase.
    Cody V; Galitsky N; Luft JR; Pangborn W; Queener SF; Gangjee A
    Acta Crystallogr D Biol Crystallogr; 2002 Sep; 58(Pt 9):1393-9. PubMed ID: 12198294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity correlations for three pyrido[2,3-d]pyrimidine antifolates binding to human and Pneumocystis carinii dihydrofolate reductase.
    Cody V; Pace J; Namjoshi OA; Gangjee A
    Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):799-803. PubMed ID: 26057816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of a holoenzyme complex of mouse dihydrofolate reductase with NADPH and a ternary complex with the potent and selective inhibitor 2,4-diamino-6-(2'-hydroxydibenz[b,f]azepin-5-yl)methylpteridine.
    Cody V; Pace J; Rosowsky A
    Acta Crystallogr D Biol Crystallogr; 2008 Sep; 64(Pt 9):977-84. PubMed ID: 18703847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations of inhibitor kinetics for Pneumocystis jirovecii and human dihydrofolate reductase with structural data for human active site mutant enzyme complexes.
    Cody V; Pace J; Makin J; Piraino J; Queener SF; Rosowsky A
    Biochemistry; 2009 Mar; 48(8):1702-11. PubMed ID: 19196009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure determination of tetrahydroquinazoline antifolates in complex with human and Pneumocystis carinii dihydrofolate reductase: correlations between enzyme selectivity and stereochemistry.
    Cody V; Luft JR; Pangborn W; Gangjee A; Queener SF
    Acta Crystallogr D Biol Crystallogr; 2004 Apr; 60(Pt 4):646-55. PubMed ID: 15039552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refolding of recombinant Pneumocystis carinii dihydrofolate reductase and characterization of the enzyme.
    Delves CJ; Ballantine SP; Tansik RL; Baccanari DP; Stammers DK
    Protein Expr Purif; 1993 Feb; 4(1):16-23. PubMed ID: 8425104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and characterization of recombinant human-derived Pneumocystis carinii dihydrofolate reductase.
    Ma L; Kovacs JA
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3092-6. PubMed ID: 11036028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A plasmid-encoded dihydrofolate reductase from trimethoprim-resistant bacteria has a novel D2-symmetric active site.
    Narayana N; Matthews DA; Howell EE; Nguyen-huu X
    Nat Struct Biol; 1995 Nov; 2(11):1018-25. PubMed ID: 7583655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity in structure-based drug design: identification of a novel, selective inhibitor of Pneumocystis carinii dihydrofolate reductase.
    Gschwend DA; Sirawaraporn W; Santi DV; Kuntz ID
    Proteins; 1997 Sep; 29(1):59-67. PubMed ID: 9294866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary crystallographic data for Pneumocystis carinii dihydrofolate reductase.
    Stammers DK; Delves C; Ballantine S; Jones EY; Stuart DI; Achari A; Bryant PK; Champness JN
    J Mol Biol; 1993 Mar; 230(2):679-80. PubMed ID: 8464076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure of mouse L1210 dihydrofolate reductase-drug complexes and the construction of a model of human enzyme.
    Stammers DK; Champness JN; Beddell CR; Dann JG; Eliopoulos E; Geddes AJ; Ogg D; North AC
    FEBS Lett; 1987 Jun; 218(1):178-84. PubMed ID: 3595861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and properties of recombinant Pneumocystis carinii dihydrofolate reductase.
    Sirawaraporn W; Edman JC; Santi DV
    Protein Expr Purif; 1991; 2(5-6):313-6. PubMed ID: 1821803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.